View Related Items
Category 3 - THERAPEUTIC PROCEDURES
TN.1.16
Facial Injections of Poly-L-Lactic Acid - (Items 14201 and 14202)
Poly-L-lactic acid is listed within the standard arrangements on the Pharmaceutical Benefits Scheme (PBS) as an Authority Required listing for initial and maintenance treatments, for facial administration only, of severe facial lipoatrophy caused by therapy for HIV infection.
Related Items
Category 3 - THERAPEUTIC PROCEDURES
14201 - Additional Information
POLY-L-LACTIC ACID, one or more injections of, for the initial session only, for the treatment of severe facial lipoatrophy caused by antiretroviral therapy, when prescribed in accordance with the National Health Act 1953 - once per patient
Fee: $260.70 Benefit: 75% = $195.55 85% = $221.60
(See para TN.1.16 of explanatory notes to this Category)
Category 3 - THERAPEUTIC PROCEDURES
14202 - Additional Information
POLY-L-LACTIC ACID, one or more injections of (subsequent sessions), for the continuation of treatment of severe facial lipoatrophy caused by antiretroviral therapy, when prescribed in accordance with the National Health Act 1953
Fee: $131.95 Benefit: 75% = $99.00 85% = $112.20
(See para TN.1.16 of explanatory notes to this Category)
Legend
- Assist - Addition/Deletion of (Assist.)
- Amend - Amended Description
- Anaes - Anaesthetic Values Amended
- Emsn - EMSN Change
- Fee - Fee Amended
- Renum - Item Number Change (renumbered)
- New - New Item
- NewMin - New Item (previous Ministerial Determination)
- Qfe - QFE Change